## Abstract In a prospective randomized study, 25 patients with benign bone tumors were surgically treated with either bioactive glass S53P4 (BG) or autogenous bone (AB) as bone graft material. X‐rays were taken preoperatively and postoperatively at 2 weeks and at 3, 8, 12, 18, 24, and 36 months. I
Molecular Basis for Action of Bioactive Glasses as Bone Graft Substitute
✍ Scribed by Välimäki, V.-V. ;Aro, H. T.
- Book ID
- 125488220
- Publisher
- SAGE Publications
- Year
- 2006
- Tongue
- English
- Weight
- 648 KB
- Volume
- 95
- Category
- Article
- ISSN
- 1457-4969
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
This new work is dedicated to glasses and their variants which can be used as biomaterials to repair diseased and damaged tissues. Bio-glasses are superior to other biomaterials in many applications, such as healing bone by signaling stem cells to become bone cells. **Key features:** * First book
The applicability of bioactive glass (BG) granules as a levels of TGF-ͱ1 and type I collagen mRNAs during the substitute for bone grafts was tested by comparing the first 2 weeks of healing, whereas BG-filled defects showed histologic, histomorphometric, and molecular biologic heal-biphasic expressi